Related Experiment Video
Updated: May 30, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
A delayed fatal metastatic Hürthle cell carcinoma
S Oaleed Noordally1, Schoeb Sohawon, Ruth Duttmann
1Department of Otolaryngology and Cervico-Facial Surgery, CHU Brugmann, Free University of Brussels, Brussels, Belgium. Sheikoaleed.Noordally@chu-brugmann.be
Abstract:
Hürthle (oxyphilic or oncocytic) cell carcinoma is a variant of follicular cell carcinoma of thyroid. Although this entity of thyroid cancer is well known, its occurrence in young patients has scarcely been reported. We report a case of a 26 year-old male patient, at the time of diagnosis, of Turkish origin, who developed a tracheal, pulmonary and mediastinal metastatic Hürthle cell carcinoma with bilateral cervical and mediastinal lymphadenopathies. This case illustrates an aggressive and metastatic cancer at the time of diagnosis and resistant to all treatment options including surgery, chemotherapy and radioactive iodine.
Related Concept Videos
Huntington Disease l: Introduction
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
